COMPASS THERAPEUTICS, INC. Interest Expense
COMPASS THERAPEUTICS, INC. (CMPX) reported Interest Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-03-15
- COMPASS THERAPEUTICS, INC. interest expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. interest expense for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. interest expense for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- COMPASS THERAPEUTICS, INC. interest expense for fiscal 2021 was $370.00K, a 59.25% decline from fiscal 2020.
- COMPASS THERAPEUTICS, INC. interest expense for fiscal 2020 was $908.00K.
- COMPASS THERAPEUTICS, INC. interest expense for fiscal 2020 was $5.38K.
| Period end | Interest Expense 0 month | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $39.00K derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-01 | $0.00 10-Q · filed 2022-08-01 | $39.00K derived: sum of 3 quarters · filed 2023-03-15 | $117.00K derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $39.00K derived: sum of 2 quarters · filed 2023-03-15 | $117.00K derived: sum of 3 quarters · filed 2023-03-15 | $228.00K derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $117.00K derived: sum of 2 quarters · filed 2023-03-15 | $228.00K derived: sum of 3 quarters · filed 2023-03-15 | $370.00K 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $78.00K 10-Q · filed 2022-11-09 | $189.00K derived: sum of 2 quarters · filed 2022-11-09 | $331.00K 10-Q · filed 2022-11-09 | $509.00K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $111.00K 10-Q · filed 2022-08-01 | $253.00K 10-Q · filed 2022-08-01 | $431.00K derived: sum of 3 quarters · filed 2022-08-01 | $643.00K derived: sum of 4 quarters · filed 2022-08-01 | ||
| 2021-03-31 | $142.00K 10-Q · filed 2022-05-09 | $320.00K derived: sum of 2 quarters · filed 2022-05-09 | $532.00K derived: sum of 3 quarters · filed 2022-05-09 | $774.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $390.00K derived: sum of 2 quarters · filed 2022-03-18 | $632.00K derived: sum of 3 quarters · filed 2022-03-18 | $908.00K 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $212.00K 10-Q · filed 2021-11-12 | $454.00K derived: sum of 2 quarters · filed 2021-11-12 | $730.00K 10-Q · filed 2021-11-12 | $731.44K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $242.00K 10-Q · filed 2021-08-16 | $518.00K 10-Q · filed 2021-08-16 | $519.44K derived: sum of 3 quarters · filed 2021-08-16 | $831.44K derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $276.00K 10-Q · filed 2021-04-30 | $277.44K derived: sum of 2 quarters · filed 2021-04-30 | $589.44K derived: sum of 3 quarters · filed 2021-04-30 | $5.38K 10-K · filed 2020-06-08 | ||
| 2019-12-31 | $1.44K 10-Q · filed 2020-02-14 | $313.44K derived: sum of 2 quarters · filed 2020-11-09 | $3.84K 10-Q · filed 2020-02-14 | $1.23M 10-K · filed 2021-03-05 | ||
| 2019-09-30 | $312.00K 10-Q · filed 2020-11-09 | $1.25K 10-Q · filed 2019-11-13 | $2.40K 10-Q · filed 2019-11-13 | $944.00K 10-Q · filed 2020-11-09 | $627.93K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $314.00K 10-Q · filed 2020-08-13 | $1.14K 10-Q · filed 2019-08-13 | $632.00K 10-Q · filed 2020-08-13 | $315.93K derived: sum of 3 quarters · filed 2020-08-13 | $316.70K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $1.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | $1.93K derived: sum of 2 quarters · filed 2020-06-08 | $2.70K derived: sum of 3 quarters · filed 2020-06-08 | $3.28K 10-K · filed 2020-06-08 | ||
| 2018-12-31 | $875.00 10-Q · filed 2020-02-14 | $1.65K derived: sum of 2 quarters · filed 2020-02-14 | $2.23K 10-Q · filed 2020-02-14 | |||
| 2018-09-30 | $771.00 10-Q · filed 2019-11-13 | $1.35K 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | $580.00 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | $52.00 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |